Immatics NV (IMTX)
10.76
-0.14
(-1.24%)
USD |
NASDAQ |
May 03, 15:15
Immatics Total Liabilities (Quarterly): 314.91M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 314.91M |
| September 30, 2023 | 200.80M |
| June 30, 2023 | 208.63M |
| March 31, 2023 | 194.54M |
| December 31, 2022 | 208.75M |
| September 30, 2022 | 237.12M |
| June 30, 2022 | 254.21M |
| March 31, 2022 | 185.49M |
| Date | Value |
|---|---|
| December 31, 2021 | 170.49M |
| September 30, 2021 | 189.93M |
| June 30, 2021 | 166.68M |
| March 31, 2021 | 168.91M |
| December 31, 2020 | 205.72M |
| September 30, 2020 | 189.46M |
| June 30, 2020 | 197.86M |
| December 31, 2019 | 196.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
166.68M
Minimum
Jun 2021
314.91M
Maximum
Dec 2023
205.60M
Average
197.01M
Median
Total Liabilities (Quarterly) Benchmarks
| MorphoSys AG | 2.186B |
| Affimed NV | 43.50M |
| InflaRx NV | 19.48M |
| BioNTech SE | 3.051B |
| CureVac NV | 299.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 563.72M |
| Shareholders Equity (Quarterly) | 248.81M |
| Current Ratio | 2.870 |